Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Anavex Life Sciences Corp
AVXL
Healthcare
Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of...
neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease, and other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2 (MECP2). The Company’s product candidates include NAVEX 3-71, ANAVEX 1-41, and ANAVEX 1066. ANAVEX 3-71 is a central nervous system (CNS) penetrable potential disease modifying treatment for cognitive impairments. ANAVEX 1-41 is a sigma-1 agonist.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AVXL)
New Post
View:
Posts & Comments
Threaded Posts
(8)
•••
hoffbag
X
View Profile
View Bullboard History
Post by
hoffbag
on Nov 25, 2023 5:20pm
Not a lot of respect here….
For their data. Seems like everyone is doubting efficacy. But the approved products are NG also? Well if the pharma gods and the FDA are wrong and Anavex gets EMA approval there are
...more
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Jun 30, 2021 8:24am
$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKIN
$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKING! https://www.aviseanalytics.com/anavex2-73-a-potential-blockbuster-drug-in-the-making/
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Jun 22, 2021 8:47am
AVXL 5 MOST PROMISING ALZHEIMER’S DISEASE STOCK!
5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! https://www.aviseanalytics.com/5-most-promising-alzheimers-disease-stock/
(6)
•••
billybob22
X
View Profile
View Bullboard History
Post by
billybob22
on Feb 04, 2021 7:45am
ALL ABOARD
Dont miss this train leaving the station.............
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Dec 02, 2020 5:04pm
End of Month - September 2020
End of the Month (EOM) report for November 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.33 AVXL closed on 10/30/2020 at US$5.90 - This is a 9.7%, a US$O.57, Loss for
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Oct 31, 2020 9:58pm
End of Month - October 2020
End of the Month (EOM) report for October 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.90 AVXL closed on 09/30/2020 at US$4.55 - This is a 27.9%, a US$1.35, Gain for October
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Oct 01, 2020 5:24pm
End of Month - September 2020
End of the Month (EOM) report for September 2020 for Anavex Life Sciences Corp. - AVXL closed on 07/31/2020 at US$4.55 AVXL closed on 08/31/2020 at US$4.24 - This is a 7.3%, a 31-cent, Gain for
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Sep 01, 2020 7:49am
End of Month - August 2020
End of the Month (EOM) report for August 2020 for Anavex Life Sciences Corp. - AVXL closed on 08/31/2020 at US$4.24 AVXL closed on 07/31/2020 at US$4.22 - This is a 0.5%, a 2-cent, Gain for August
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Aug 02, 2020 5:01am
End of Month - July 2020
End of the Month (EOM) report for July 2020 for Anavex Life Sciences Corp. - AVXL closed on 07/31/2020 at US$4.22 AVXL closed on 06/30/2020 at US$4.92 - This is a 14.2%, a 70-cent, Loss for July. - S
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Jul 01, 2020 5:21am
End of First Half - 2020
End of the First Half Report for 2020 for Anavex Life Sciences Corp. - AVXL closed on 06/30/2020 at US$4.92 AVXL closed on 12/31/2019 at US$2.59 - This is a 90.0%, a US$2.33, GAIN for the first half
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Feb 02, 2020 5:00am
End of Month - January 2020
End of the Month (EOM) report for January 2020 for Anavex Life Sciences Corp. - AVXL closed on 01/31/2020 at US$2.86 AVXL closed on 12/31/2019 at US$2.59 AVXL closed on 11/29/2019 at US$2.40 - This is
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Jan 02, 2020 4:15am
End of Year; End of Month; 2019, December
End of the Year Report for 2019 - AVXL closed on 12/31/2019 at US$2.59 AVXL closed on 12/31/2018 at US$1.56 - This is a GAIN of 66.0%, or US$1.30, for the year 2019. - AVLX's 2019
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Dec 04, 2019 3:54pm
News Release
AVXL Closed up 57-cents, 23.3%, on today’s, December 4, News Release. - Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019
...more
(161)
•••
R_J_
X
View Profile
View Bullboard History
Post by
R_J_
on Dec 01, 2019 7:58am
End of Month - November 2019
End of the Month (EOM) report for November 2019. - AVXL closed on 11/29/2019 at US$2.40 AVXL closed on 10/31/2019 at US$2.72 - This is a 11.8%, a 32-cent, loss for November. - S&P 500 Index
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden